The BioPharma sector is under constant pressure to bring more novel therapies to market, more quickly and affordably. Attaining this goal requires improved operational control and continuous real-time ...
Unlike traditional manufacturing processes in the biotechnology industry (e.g., monoclonal antibodies, gene therapies, etc.) where there are extensive downstream purification steps after the initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback